RNF168
protein-codingring finger protein 168, the group of Ring finger proteins
Gene summary
This gene encodes an E3 ubiquitin ligase protein that contains a RING finger, a motif present in a variety of functionally distinct proteins and known to be involved in protein-DNA and protein-protein interactions. The protein is involved in DNA double-strand break (DSB) repair. Mutations in this gene result in Riddle syndrome. [provided by RefSeq, Sep 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: ClinGen
RNF168 was first reported in relation to autosomal recessive RIDDLE syndrome in 2009 (Stewart et al., PMID: 19203578). RIDDLE syndrome is named for its clinical features which include Radiosensitivity, ImmunoDeficiency, Dysmorphic features, and LEarning difficulties. Four variants (nonsense and frameshift) that have been reported in 3 probands in 3 publications are included in this curation (PMIDs: 19203578, 21394101, 29255463). Information regarding the phenotype of heterozygous carriers is limited; however, one parent of a proband was noted to have B cell chronic lymphocytic leukemia (PMID: 19203578). The mechanism of pathogenicity is loss of function. This gene-disease association is supported by biochemical studies, functional and rescue assays, and an animal model (PMIDs: 19203578, 17940005, 29255463, 21394101, 21552324). RNF168 is critical for double stranded break repair (PMID: 19203578), and RIDDLE syndrome patient cells show defects in 53BP1-mediated DNA damage signaling (PMID: 17940005, 29255463). These defects are rescued by wild type RNF168 (PMID: 19203578, 21394101). RNF168 knockout mice have radiosensitivity and immunodeficiency consistent with RIDDLE syndrome (PMID: 21552324). In summary, RNF168 is definitively associated with autosomal recessive RIDDLE syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen SCID/CID GCEP on the meeting date July 21, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012764
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Craniofacial; Musculoskeletal; Neurologic; Oncologic
Intervention: Allergy/Immunology/Infectious; Oncologic
Rationale: Individuals have been described with immunodefiency, as well as radiosensitivity, and thus preventive measures and prophylaxis and early and aggressive treatment of infections may be warranted
Comments: It has been suggested that heterozygotes may demonstrate an increased risk of oncologic processes as well
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RNF168 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152617.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 103 | 1 | 105 | ||
| missense | 168 | 23 | 6 | 197 | ||
| nonsense | 2 | 6 | 3 | 11 | ||
| start loss | 0 | |||||
| frameshift | 20 | 5 | 7 | 32 | ||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 22 | 14 | 180 | 126 | 7 | 349 |
Highest pathogenic variant AF is 0.00026809218
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689830.2 | 6 | MANE Select | |
| Ensembl | ENSP00000320898.3 | 6 | MANE Select | |
| Ensembl | ENSP00000396712.1 | 2 | Standard | |
| Ensembl | ENSP00000677129.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- ATM Signaling Network in Development and Disease
- HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
- DNA Repair
- Nonhomologous End-Joining (NHEJ)
- DNA Double-Strand Break Repair
Biological Process
- double-strand break repair
- double-strand break repair via nonhomologous end joining
- ubiquitin-dependent protein catabolic process
- cellular response to DNA damage stimulus
- response to ionizing radiation
Molecular Function
- chromatin binding
- ubiquitin-protein transferase activity
- protein binding
- nucleosome binding
- histone binding
Cellular Component
- ubiquitin ligase complex
- nucleus
- nucleoplasm
- cytosol
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318037
- Coding exons
- 6
- Length
- 34986
- Individuals with no LoFs
- 125629
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 118
- Defined
- 125747
- p
- 0.000469
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.392 | 319 | 300 | 1.06 | 0.0000154 | 3760 |
| Missense (PolyPhen) | 48 | 51.045 | 0.94034 | 661 | ||
| Synonymous | -0.505 | 125 | 118 | 1.06 | 0.00000663 | 1068 |
| Loss of Function | 0.763 | 22 | 26.2 | 0.839 | 0.00000137 | 325 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00075 | 0.00075 | rare |
| Ashkenazi Jewish | 0.00070 | 0.00069 | rare |
| East Asian | 0.00049 | 0.00049 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00044 | 0.00044 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase required for accumulation of repair proteins to sites of DNA damage. Acts with UBE2N/UBC13 to amplify the RNF8-dependent histone ubiquitination. Recruited to sites of DNA damage at double-strand breaks (DSBs) by binding to ubiquitinated histone H2A and H2AX and amplifies the RNF8- dependent H2A ubiquitination, promoting the formation of 'Lys-63'- linked ubiquitin conjugates. This leads to concentrate ubiquitinated histones H2A and H2AX at DNA lesions to the threshold required for recruitment of TP53BP1 and BRCA1. Also recruited at DNA interstrand cross-links (ICLs) sites and promotes accumulation of 'Lys-63'-linked ubiquitination of histones H2A and H2AX, leading to recruitment of FAAP20/C1orf86 and Fanconi anemia (FA) complex, followed by interstrand cross-link repair. H2A ubiquitination also mediates the ATM-dependent transcriptional silencing at regions flanking DSBs in cis, a mechanism to avoid collision between transcription and repair intermediates. Also involved in class switch recombination in immune system, via its role in regulation of DSBs repair. Following DNA damage, promotes the ubiquitination and degradation of JMJD2A/KDM4A in collaboration with RNF8, leading to unmask H4K20me2 mark and promote the recruitment of TP53BP1 at DNA damage sites. Not able to initiate 'Lys-63'-linked ubiquitination in vitro; possibly due to partial occlusion of the UBE2N/UBC13-binding region. Catalyzes monoubiquitination of 'Lys-13' and 'Lys-15' of nucleosomal histone H2A (H2AK13Ub and H2AK15Ub, respectively). {ECO:0000255|HAMAP- Rule:MF_03066, ECO:0000269|PubMed:19203578, ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:20550933, ECO:0000269|PubMed:22373579, ECO:0000269|PubMed:22705371, ECO:0000269|PubMed:22713238, ECO:0000269|PubMed:22742833, ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:23760478}.;
- Disease
- DISEASE: Riddle syndrome (RIDDLES) [MIM:611943]: Characterized by increased radiosensitivity, immunodeficiency, mild motor control and learning difficulties, facial dysmorphism, and short stature. Defects are probably due to impaired localization of TP53BP1 and BRCA1 at DNA lesions. {ECO:0000269|PubMed:19203578}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0905
Intolerance Scores
- LoFtool
- 0.776
- RVIS EVS
- 0.42
- RVIS percentile EVS
- 77.26
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.938
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |